Epidemiology of Clostridium difficile in Germany based on a single center long-term surveillance and German-wide genotyping of recent isolates provided to the advisory laboratory for diagnostic reasons

International Journal of Medical Microbiology

Volumn 305, Issue 7, 2015, Pages 807-813

  von Müller, Lutz ^a,b   Mock, Markus ^a   Halfmann, Alexander ^a   Stahlmann, Julia ^a   Simon, Arne ^a   Herrmann, Mathias ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b Microbiology and Hygiene (LMH)   (Germany)

Author keywords

Clostridium difficile; Epidemiology; Germany; SlpA sequence typing

Indexed keywords

PROTEIN A;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIUM ISOLATE; CHILD; CLOSTRIDIUM DIFFICILE INFECTION; CONTROLLED STUDY; DIAGNOSTIC TEST; DIARRHEA; DISEASE SURVEILLANCE; EPIDEMIC; GENOTYPE; GEOGRAPHIC MAPPING; GERMANY; GROUPS BY AGE; HOSPITAL PATIENT; HUMAN; INCIDENCE; INFANT; LABORATORY; MAJOR CLINICAL STUDY; MOLECULAR TYPING; NONHUMAN; PEPTOCLOSTRIDIUM DIFFICILE; SEQUENCE ANALYSIS; YOUNG ADULT; AGE; CLASSIFICATION; CLOSTRIDIUM INFECTIONS; CROSS INFECTION; EPIDEMIOLOGICAL MONITORING; FEMALE; GENETICS; GENOTYPING TECHNIQUE; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; NEWBORN; PRESCHOOL CHILD; RETROSPECTIVE STUDY; UNIVERSITY HOSPITAL; VERY ELDERLY;

ACADEMIC MEDICAL CENTERS; ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; CROSS INFECTION; DIARRHEA; EPIDEMIOLOGICAL MONITORING; FEMALE; GENOTYPING TECHNIQUES; GERMANY; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84944277359     PISSN: 14384221     EISSN: 16180607     Source Type: Journal    
DOI: 10.1016/j.ijmm.2015.08.035     Document Type: Article

References (49)

1. Arvand M., Hauri A.M., Zaiss N.H., Witte W., Bettge-Weller G. Clostridium difficile ribotypes 001, 017, and 027 are associated with lethal C. difficile infection in Hesse, Germany. Eurosurveillance 2009, 19(10).
2. Bakker D., Smits W.K., Kuijper E.J., Corver J. TcdC does not significantly repress toxin expression in Clostridium difficile 630DeltaErm. PloS One 2012, 7:e43247.
3. Bianco M., Fedele G., Quattrini A., Spigaglia P., Barbanti F., Mastrantonio P., Ausiello C.M. Immunomodulatory activities of surface-layer proteins obtained from epidemic and hypervirulent Clostridium difficile strains. J. Med. Microbiol. 2011, 60:1162-1167.
4. Brown K.A., Daneman N., Arora P., Moineddin R., Fisman D.N. The co-seasonality of pneumonia and influenza with Clostridium difficile infection in the United States, 1993-2008. Am. J. Epidemiol. 2013, 178:118-125.
5. Carter G.P., Douce G.R., Govind R., Howarth P.M., Mackin K.E., Spencer J., Buckley A.M., Antunes A., Kotsanas D., Jenkin G.A., Dupuy B., Rood J.I., Lyras D. The anti-sigma factor TcdC modulates hypervirulence in an epidemic BI/NAP1/027 clinical isolate of Clostridium difficile. PLoS Pathogens 2011, 7:e1002317.
6. Chitnis A.S., Holzbauer S.M., Belflower R.M., Winston L.G., Bamberg W.M., Lyons C., Farley M.M., Dumyati G.K., Wilson L.E., Beldavs Z.G., Dunn J.R., Gould L.H., MacCannell D.R., Gerding D.N., McDonald L.C., Lessa F.C. Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011. J. Am. Med. Assoc. Intern. Med. 2013, 173:1359-1367.
7. Cohen S.H., Gerding D.N., Johnson S., Kelly C.P., Loo V.G., McDonald L.C., Pepin J., Wilcox M.H. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect. Control Hosp. Epidemiol. 2010, 31:431-455.
8. Davies K.A., Longshaw C.M., Davis G.L., Bouza E., Barbut F., Barna Z., Delmee M., Fitzpatrick F., Ivanova K., Kuijper E., Macovei I.S., Mentula S., Mastrantonio P., von Müller L., Oleastro M., Petinaki E., Pituch H., Noren T., Novakova E., Nyc O., Rupnik M., Schmid D., Wilcox M.H. Underdiagnosis of Clostridium difficile across Europe: the European, multicentre, prospective, biannual, point-prevalence study of clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID). Lancet Infect. Dis. 2014, 14:1208-1219.
9. Debast S.B., Bauer M.P., Kuijper E.J. European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection. Clin. Microbiol. Infect. 2014, 20(Suppl 2):1-26. (Committee).
10. Dingle K.E., Didelot X., Ansari M.A., Eyre D.W., Vaughan A., Griffiths D., Ip C.L., Batty E.M., Golubchik T., Bowden R., Jolley K.A., Hood D.W., Fawley W.N., Walker A.S., Peto T.E., Wilcox M.H., Crook D.W. Recombinational switching of the Clostridium difficile S-layer and a novel glycosylation gene cluster revealed by large-scale whole-genome sequencing. J. Infect. Dis. 2013, 207:675-686.
11. Dubberke E.R., Carling P., Carrico R., Donskey C.J., Loo V.G., McDonald L.C., Maragakis L.L., Sandora T.J., Weber D.J., Yokoe D.S., Gerding D.N. Strategies to prevent Clostridium difficile infections in acute care hospitals: 2014 update. Infect. Control Hosp. Epidemiol. 2014, 35:628-645.
12. El Feghaly R.E., Tarr P.I. Editorial commentary: Clostridium difficile in children: colonization and consequences. Clin. Infect. Dis. 2013, 57:9-12.
13. Enoch D.A., Butler M.J., Pai S., Aliyu S.H., Karas J.A. Clostridium difficile in children: colonisation and disease. J. Infect. 2011, 63:105-113.
14. Freeman J., Fawley W., Baines S., Wilcox M. Measurement of toxin production by Clostridium difficile. Lancet 2006, 367:982-983. (author reply).
15. Gastmeier P., Schroder C., Behnke M., Meyer E., Geffers C. Dramatic increase in vancomycin-resistant enterococci in Germany. J. Antimicrob. Chemother. 2014, 69:1660-1664.
16. Gerding D.N., Johnson S., Rupnik M., Aktories K. Clostridium difficile binary toxin CDT: mechanism, epidemiology, and potential clinical importance. Gut Microbes 2014, 5:15-27.
17. Goorhuis A., Bakker D., Corver J., Debast S.B., Harmanus C., Notermans D.W., Bergwerff A.A., Dekker F.W., Kuijper E.J. Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. Clin. Infect. Dis. 2008, 47:1162-1170.
18. Goorhuis A., Debast S.B., van Leengoed L.A., Harmanus C., Notermans D.W., Bergwerff A.A., Kuijper E.J. Clostridium difficile PCR ribotype 078: an emerging strain in humans and in pigs?. J. Clin. Microbiol. 2008, 46:1157. (1157; author reply).
19. Goorhuis A., Debast S.B., Dutilh J.C., van Kinschot C.M., Harmanus C., Cannegieter S.C., Hagen E.C., Kuijper E.J. Type-specific risk factors and outcome in an outbreak with 2 different Clostridium difficile types simultaneously in 1 hospital. Clin. Infect. Dis. 2011, 53:860-869.
20. He M., Miyajima F., Roberts P., Ellison L., Pickard D.J., Martin M.J., Connor T.R., Harris S.R., Fairley D., Bamford K.B., D'Arc S., Brazier J., Brown D., Coia J.E., Douce G., Gerding D., Kim H.J., Koh T.H., Kato H., Senoh M., Louie T., Michell S., Butt E., Peacock S.J., Brown N.M., Riley T., Songer G., Wilcox M., Pirmohamed M., Kuijper E., Hawkey P., Wren B.W., Dougan G., Parkhill J., Lawley T.D. Emergence and global spread of epidemic healthcare-associated Clostridium difficile. Nat. Genet. 2013, 45:109-113.
21. Hensgens M.P., Goorhuis A., Notermans D.W., van Benthem B.H., Kuijper E.J. Decrease of hypervirulent Clostridium difficile PCR ribotype 027 in the Netherlands. EuroSurveillance 2009, 14.
22. Indra A., Huhulescu S., Schneeweis M., Hasenberger P., Kernbichler S., Fiedler A., Wewalka G., Allerberger F., Kuijper E.J. Characterization of Clostridium difficile isolates using capillary gel electrophoresis-based PCR ribotyping. J. Med. Microbiol. 2008, 57:1377-1382.
23. Jansen A., Kleinkauf N., Weiss B., Zaiss N.H., Witte W., Bornhofen B., Kist M., von Eichel-Streiber C., Neumann M., Michels H., Eckmanns T. Emergence of Clostridium difficile ribotype 027 in Germany: epidemiological and clinical characteristics. Z. Gastroenterol. 2010, 48:1120-1125.
24. Joost I., Speck K., Herrmann M., von Müller L. Characterisation of Clostridium difficile isolates by slpA and tcdC gene sequencing. Int. J. Antimicrob. Agents 2009, 33(Suppl 1):S13-S18.
25. Karczewski J., Zorman J., Wang S., Miezeiewski M., Xie J., Soring K., Petrescu I., Rogers I., Thiriot D.S., Cook J.C., Chamberlin M., Xoconostle R.F., Nahas D.D., Joyce J.G., Bodmer J.L., Heinrichs J.H., Secore S. Development of a recombinant toxin fragment vaccine for Clostridium difficile infection. Vaccine 2014, 32:2812-2818.
26. Kato H., Yokoyama T., Arakawa Y. Typing by sequencing the slpA gene of Clostridium difficile strains causing multiple outbreaks in Japan. J. Med. Microbiol. 2005, 54:167-171.
27. Killgore G., Thompson A., Johnson S., Brazier J., Kuijper E., Pepin J., Frost E.H., Savelkoul P., Nicholson B., van den Berg R.J., Kato H., Sambol S.P., Zukowski W., Woods C., Limbago B., Gerding D.N., McDonald L.C. Comparison of seven techniques for typing international epidemic strains of Clostridium difficile: restriction endonuclease analysis, pulsed-field gel electrophoresis, PCR-ribotyping, multilocus sequence typing, multilocus variable-number tandem-repeat analysis, amplified fragment length polymorphism, and surface layer protein A gene sequence typing. J. Clin. Microbiol. 2008, 46:431-437.
28. Kleinkauf N., Weiss B., Jansen A., Eckmanns T., Bornhofen B., Kuehnen E., Weil H.P., Michels H. Confirmed cases and report of clusters of severe infections due to Clostridium difficile PCR ribotype 027 in Germany. EuroSurveillance 2007, 12.
29. Kuehne S.A., Cartman S.T., Heap J.T., Kelly M.L., Cockayne A., Minton N.P. The role of toxin A and toxin B in Clostridium difficile infection. Nature 2010, 467:711-713.
30. Kuijper E.J., Barbut F., Brazier J.S., Kleinkauf N., Eckmanns T., Lambert M.L., Drudy D., Fitzpatrick F., Wiuff C., Brown D.J., Coia J.E., Pituch H., Reichert P., Even J., Mossong J., Widmer A.F., Olsen K.E., Allerberger F., Notermans D.W., Delmee M., Coignard B., Wilcox M., Patel B., Frei R., Nagy E., Bouza E., Marin M., Akerlund T., Virolainen-Julkunen A., Lyytikainen O., Kotila S., Ingebretsen A., Smyth B., Rooney P., Poxton I.R., Monnet D.L. Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008. EuroSurveillance 2008, 13.
31. Kuijper E.J., van den Berg R.J., Debast S., Visser C.E., Veenendaal D., Troelstra A., van der Kooi T., van den Hof S., Notermans D.W. Clostridium difficile ribotype 027, toxinotype III, the Netherlands. Emerg. Infect. Dis. 2006, 12:827-830.
32. Natarajan M., Walk S.T., Young V.B., Aronoff D.M. A clinical and epidemiological review of non-toxigenic Clostridium difficile. Anaerobe 2013, 22:1-5.
33. Pepin J., Saheb N., Coulombe M.A., Alary M.E., Corriveau M.P., Authier S., Leblanc M., Rivard G., Bettez M., Primeau V., Nguyen M., Jacob C.E., Lanthier L. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Clin. Infect. Dis. 2005, 41:1254-1260.
34. Rupnik M., Wilcox M.H., Gerding D.N. Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat. Rev. Microbiol. 2009, 7:526-536.
35. Sethi A.K., Al-Nassir W.N., Nerandzic M.M., Donskey C.J. Skin and environmental contamination with vancomycin-resistant Enterococci in patients receiving oral metronidazole or oral vancomycin treatment for Clostridium difficile-associated disease. Infect. Control Hosp. Epidemiol. 2009, 30:13-17.
36. Shim J.K., Johnson S., Samore M.H., Bliss D.Z., Gerding D.N. Primary symptomless colonisation by Clostridium difficile and decreased risk of subsequent diarrhoea. Lancet 1998, 351:633-636.
37. Smits W.K. Hype or hypervirulence: a reflection on problematic C. difficile strains. Virulence 2013, 4:592-596.
38. Stahlmann J., Schonberg M., Herrmann M., von Muller L. Detection of nosocomial Clostridium difficile infections with toxigenic strains despite negative toxin A/B testing on stool samples. Clin. Microbiol. Infect. 2014, 20(9):O590-O592. 10.1111/1469-0691.12558.
39. Steglich M., Radovic A.A., Nitsche A., Kohl T., Niemann S., von Muller L., Herrmann M., Nübel U. Bayesian phylogeography analysis of Clostridium difficile in Germany: a critical evaluation. Biospektrum Suppl. 2014, MSV06.
40. Tenover F.C., Akerlund T., Gerding D.N., Goering R.V., Bostrom T., Jonsson A.M., Wong E., Wortman A.T., Persing D.H. Comparison of strain typing results for Clostridium difficile isolates from North America. J. Clin. Microbiol. 2011, 49:1831-1837.
41. van den Berg R.J., Schaap I., Templeton K.E., Klaassen C.H., Kuijper E.J. Typing and subtyping of Clostridium difficile isolates by using multiple-locus variable-number tandem-repeat analysis. J. Clin. Microbiol. 2007, 45:1024-1028.
42. van der Kooi T.I., Koningstein M., Lindemans A., Notermans D.W., Kuijper E., van den Berg R., Boshuizen H., Filius P.M., van den Hof S. Antibiotic use and other risk factors at hospital level for outbreaks with Clostridium difficile PCR ribotype 027. J. Med. Microbiol. 2008, 57:709-716.
43. Vardakas K.Z., Konstantelias A.A., Loizidis G., Rafailidis P.I., Falagas M.E. Risk factors for development of Clostridium difficile infection due to BI/NAP1/027 strain: a meta-analysis. Int. J. Infect. Dis. 2012, 16:e768-e773.
44. von Müller L., Halfmann A., Herrmann M. Current data and trends on the development of antibiotic resistance of Clostridium difficile. Bundesgesundheitsblatt 2012, 55:1410-1417.
45. Walker A.S., Eyre D.W., Wyllie D.H., Dingle K.E., Harding R.M., O'Connor L., Griffiths D., Vaughan A., Finney J., Wilcox M.H., Crook D.W., Peto T.E. Characterisation of Clostridium difficile hospital ward-based transmission using extensive epidemiological data and molecular typing. PLoS Med 2012, 9:e1001172.
46. Weiss B. Schwer verlaufende Clostridium-difficile-Infektionen: IfSGSurveillancedaten von 2013. Epidem. Bull. 2014, 27:233-237.
47. Weiss B., Kleinkauf N., Eckmanns T., an der Heiden M., Neumann M., Michels H., Jansen A. Risk factors related to a hospital-associated cluster of Clostridium difficile PCR ribotype 027 infections in Germany During 2007. Infect. Control Hosp. Epidemiol. 2009, 30:282-284.
48. Zaiss N.H., Weile J., Ackermann G., Kuijper E., Witte W., Nuebel U. A case of Clostridium difficile-associated disease due to the highly virulent clone of Clostridium difficile PCR ribotype 027, March 2007 in Germany. EuroSurveillance 2007, 12:12.
49. Zaiss N.H., Witte W., Nubel U. Fluoroquinolone resistance and Clostridium difficile. Ger. Emerg. Infect. Dis. 2010, 16:675-677.